These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16971264)

  • 21. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cryoglobulinemia following liver transplantation for cirrhosis secondary to hepatitis C virus infection].
    Argüello Viúdez L; Bustamante Balén M; Prieto Castillo M; Moll Guillén JL; Ramírez Palanca JJ; Berenguer Lapuerta J
    Gastroenterol Hepatol; 1999 Feb; 22(2):86-9. PubMed ID: 10193093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of HCV infection in patients with advanced cirrhosis.
    Forns X; Navasa M; Rodés J
    Hepatology; 2004 Aug; 40(2):498. PubMed ID: 15368458
    [No Abstract]   [Full Text] [Related]  

  • 24. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
    Ciesek S; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):337-50. PubMed ID: 18043552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation for hepatitis C.
    Marubashi S; Dono K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
    J Hepatobiliary Pancreat Surg; 2006; 13(5):382-92. PubMed ID: 17013711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful?
    Gallegos-Orozco JF; Charlton MR
    Liver Int; 2015 Jan; 35(1):9-11. PubMed ID: 25412996
    [No Abstract]   [Full Text] [Related]  

  • 27. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.
    Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K
    Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic management of recurrent hepatitis C after liver transplantation.
    Teixeira R; Menezes EG; Schiano TD
    Liver Int; 2007 Apr; 27(3):302-12. PubMed ID: 17355450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of liver transplantation in the treatment of viral cirrhosis C].
    Duvoux C
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B50-5. PubMed ID: 10897774
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
    Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report.
    Grasso A; De Leo P; Malfatti F; Toscanini F; Anselmo M; Menardo G
    Transplant Proc; 2008 Jun; 40(5):1783-5. PubMed ID: 18589196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
    Kuo A; Tan V; Lan B; Khalili M; Feng S; Roberts JP; Terrault NA
    Liver Transpl; 2008 Oct; 14(10):1491-7. PubMed ID: 18825708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplant for viral hepatitis and fulminant hepatic failure.
    Mukherjee S; Mahmoudi TM; Mukherjee U
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):83-100. PubMed ID: 19212311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M; Ciuffreda D; Moradpour D; Pascual M
    Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
    Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
    Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.